Skip Navigation
Skip to contents

JYMS : Journal of Yeungnam Medical Science

Indexed in: ESCI, Scopus, PubMed,
PubMed Central, CAS, DOAJ, KCI
FREE article processing charge
OPEN ACCESS
SEARCH
Search

Author index

Page Path
HOME > Browse Articles > Author index
Search
Sang Min Lee 5 Articles
Hemophagocytic lymphohistiocytosis with recurrent Kikuchi-Fujimoto disease
Sang Min Lee, Young Tae Lim, Kyung Mi Jang, Mi Jin Gu, Jong Ho Lee, Jae Min Lee
Yeungnam Univ J Med. 2021;38(3):245-250.   Published online November 11, 2020
DOI: https://doi.org/10.12701/yujm.2020.00654
  • 5,939 View
  • 105 Download
  • 4 Crossref
AbstractAbstract PDF
Kikuchi-Fujimoto disease (KFD), also known as histiocytic necrotizing lymphadenitis, is a self-limiting lymphadenitis. It is a benign disease mainly characterized by high fever, lymph node swelling, and leukopenia. Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening disease with clinical symptoms similar to those of KFD, but it requires a significantly more aggressive treatment. A 19-year-old Korean male patient was hospitalized for fever and cervical lymphadenopathy. Variable-sized lymph node enlargements with slightly necrotic lesions were detected on computed tomography. Biopsy specimen from a cervical lymph node showed necrotizing lymphadenitis with HLH. Bone marrow aspiration showed hemophagocytic histiocytosis. The clinical symptoms and the results of the laboratory test and bone marrow aspiration met the diagnostic criteria for HLH. The patient was diagnosed with macrophage activation syndrome—HLH, a secondary HLH associated with KFD. He was treated with dexamethasone (10 mg/m2/day) without immunosuppressive therapy or etoposide-based chemotherapy. The fever disappeared within a day, and other symptoms such as lymphadenopathy, ascites, and pleural effusion improved. Dexamethasone was reduced from day 2 of hospitalization and was tapered over 8 weeks. The patient was discharged on day 6 with continuation of dexamethasone. The patient had no recurrence at the 18-month follow-up.

Citations

Citations to this article as recorded by  
  • Histiocytic necrotizing lymphadenitis with hemophagocytic lymphohistiocytosis in adults: A single‐center analysis of 5 cases
    Qingqing Chen, Jing Zhang, Huijun Huang, Tonglu Qiu, Ze Jin, Yu Shi, Huayuan Zhu, Lei Fan, Jianyong Li, Wenyu Shi, Yi Miao
    Immunity, Inflammation and Disease.2024;[Epub]     CrossRef
  • A young Saudi female with combined hemophagocytic lympho-histiocytosis and Kikuchi’s disease: A case report
    Kamal Al-Zahrani, Batol Gasmelseed, Hesham Waaer Shadi, Rehab Y AL-Ansari
    SAGE Open Medical Case Reports.2023; 11: 2050313X2311543.     CrossRef
  • Cefalea y fiebre: no todo es lo que parece
    María Pilar Iranzo-Alcolea, Carmen Ariño-Palao, Grisell Starita-Fajardo, Andrés González-García, Cecilia Suárez-Carantoña
    Revista Española de Casos Clínicos en Medicina Interna.2023; 8(2): 105.     CrossRef
  • Kikuchi–Fujimoto disease: literature review and report of four cases
    V. G. Potapenko, V. V. Baykov, А. Yu. Markova, N. B. Mikhailova, A. S. Ter‑Grigoryan, Yu. А. Krivolapov
    Oncohematology.2022; 17(4): 48.     CrossRef
Risk factors for respiratory distress syndrome in full-term neonates
Jin Hyeon Kim, Sang Min Lee, Young Hwan Lee
Yeungnam Univ J Med. 2018;35(2):187-191.   Published online December 31, 2018
DOI: https://doi.org/10.12701/yujm.2018.35.2.187
  • 8,583 View
  • 255 Download
  • 7 Crossref
AbstractAbstract PDF
Background
Respiratory distress syndrome (RDS) is a one of the most common cause of respiratory morbidity and mortality in neonates. This study was conducted to investigate the risk factors for RDS in full-term neonates.
Methods
We conducted this retrospective study using medical records. The study group included 80 full-term neonates diagnosed with RDS and hospitalized in the neonatal intensive care unit between January 2012 and December 2016, at Yeungnam University Hospital. We analyzed sex, gestational age, birth weight, delivery method, maternal age, number of pregnancy, history of abortion, and complication of pregnancy. The control group included 116 full-time neonates who were hospitalized with jaundice during the same period.
Results
The incidence of full-term RDS was more common in males (odds ratio [OR], 3.288; 95% confidence interval [CI], 1.446-7.479), cesarean section (OR, 15.03; 95% CI, 6.381-35.423), multiparity (OR, 4.216; 95% CI, 1.568-11.335). The other factors rendered no significant results.
Conclusion
The risk factors for RDS in full-tern neonates were identified as male sex, cesarean section, and multiparity. Further studies involving more institutions are needed to clarify the risk factors for RDS in fullterm infants.

Citations

Citations to this article as recorded by  
  • The association between sex and neonatal respiratory distress syndrome
    Keren Fang, Shaojie Yue, Shuo Wang, Mingjie Wang, Xiaohe Yu, Ying Ding, Mei Lv, Yang Liu, Chuanding Cao, Zhengchang Liao
    BMC Pediatrics.2024;[Epub]     CrossRef
  • Identification of Inflammatory Mediators in Saliva Samples From Hospitalized Newborns: Potential Biomarkers?
    Vanderlei Amadeu da Rocha, Sanseray da Silveira Cruz-Machado, Isília Aparecida Silva, Pedro Augusto Carlos Magno Fernandes, Regina Pekelmann Markus, Mariana Bueno
    Clinical Nursing Research.2024;[Epub]     CrossRef
  • Global, Regional and National Trends in the Burden of Neonatal Respiratory Failure and essentials of its diagnosis and management from 1992 to 2022: a scoping review
    Joel Noutakdie Tochie, Aurelie T. Sibetcheu, Pascal Ebot Arrey-Ebot, Simeon-Pierre Choukem
    European Journal of Pediatrics.2023; 183(1): 9.     CrossRef
  • Incidence and predictors of respiratory distress syndrome among low birth weight neonates in the first seven days in Northwest Ethiopia Comprehensive Specialized Hospitals, 2023: A retrospective follow-up study
    Wubet Tazeb Wondie, Bruck Tesfaye Legesse, Gebrehiwot Berie Mekonnen, Gosa Tesfaye Degaga, Alemu Birara Zemariam, Gezahagn Demsu Gedefaw, Dereje Esubalew Abebe, Yohannes Tesfahun Kassie, Almaz Tefera Gonete, Alamirew Enyew Belay, Chalachew Adugna Wubneh
    BMJ Open.2023; 13(11): e079063.     CrossRef
  • Determinants for perinatal adverse outcomes among pregnant women with preterm premature rupture of membrane: A prospective cohort study
    Tariku Abewa Abebe, Dawit Desalegn Nima, Yitbarek Fantahun Mariye, Abebaye Aragaw Leminie
    Frontiers in Reproductive Health.2022;[Epub]     CrossRef
  • Novel predictor markers for early differentiation between transient tachypnea of newborn and respiratory distress syndrome in neonates
    Mohamed Shawky Elfarargy, Ghada M Al-Ashmawy, Sally Abu-Risha, Haidy Khattab
    International Journal of Immunopathology and Pharmacology.2021; 35: 205873842110005.     CrossRef
  • The Underlying Causes of Respiratory Distress in Late-Preterm and Full-Term Infants Are Different From Those of Early-Preterm Infants
    Li Wang, Shuqing Tang, Hui Liu, Juan Ma, Bingyi Li, Li Wu, Zhichun Feng, Yuan Shi
    Iranian Journal of Pediatrics.2020;[Epub]     CrossRef
Pulmonary artery sarcoma manifesting as a main pulmonary artery stenosis diagnosed by 18F-FDG PET/CT
Hoonhee Lee, Han Bit Park, Yun Kyung Cho, Jung Min Ahn, Sang Min Lee, Jae Seung Lee, Dae Hee Kim
Yeungnam Univ J Med. 2017;34(2):279-284.   Published online December 31, 2017
DOI: https://doi.org/10.12701/yujm.2017.34.2.279
  • 2,027 View
  • 6 Download
AbstractAbstract PDF
Pulmonary artery sarcoma (PAS) is a rare and fatal disease that often mimics chronic thromboembolic pulmonary hypertension (CTEPH); therefore, diagnosis of PAS is often delayed. Herein, a healthy 74-year-old man was presented with a 4-month history of dyspnea. Chest computed tomography showed wall thickening and stenosis in the main pulmonary artery as well as in both proximal pulmonary arteries. In order to differentiate between unusual CTEPH, vasculitis, and PAS, we performed right heart catheterization and pulmonary angiography. The mean pulmonary arterial pressure was 21 mmHg, and there was severe pulmonary artery stenosis. Thrombi on the pulmonary arterial wall lesions were observed in intravascular ultrasound and optical coherence tomography. Furthermore, the patient had a history of deep vein thrombosis. Therefore, we diagnosed unusual CTEPH. After 6 months of rivaroxaban anticoagulation therapy, a chest X-ray revealed a left lower lobe lung mass, and a positron emission tomography later showed hypermetabolic lesions in the main pulmonary artery wall, in both pulmonary arteries walls, in the lung parenchyma, and in the bones. A biopsy of the right proximal humerus lesion revealed undifferentiated intimal sarcoma. Pulmonary sarcoma is rare, but should be considered when differentially diagnosing main pulmonary artery wall thickening and stenosis. A positron emission tomography may aid in this diagnosis.
Tumor lysis syndrome following sorafenib treatment in hepatocellular carcinoma.
Shin Young Kim, Hee Yeon Kim, Yu Seung Kim, Sang Min Lee, Chang Wook Kim
Yeungnam Univ J Med. 2015;32(1):47-49.   Published online June 30, 2015
DOI: https://doi.org/10.12701/yujm.2015.32.1.47
  • 2,247 View
  • 18 Download
  • 2 Crossref
AbstractAbstract PDF
Sorafenib is indicated for the treatment of advanced hepatocellular carcinoma (HCC), but although rare, tumor lysis syndrome (TLS) can be fatal in HCC patients with a large tumor burden. The authors describe the case of a 55-year-old hepatitis B carrier who visited our clinic with progressive dyspnea for 3 weeks. Chest and abdominal computed tomography revealed a huge HCC in the left lobe of the liver with invasion of the inferior vena cava, right atrium, and pulmonary arteries. After 8 days of sorafenib administration, TLS was diagnosed based on the characteristic findings of hyperuricemia, hyperkalemia, and acute kidney injury with massive tumor necrosis by follow-up imaging. Despite discontinuation of sorafenib and supportive care, the patient's clinical course rapidly deteriorated. The authors describe a rare but fatal complication that occurred soon after sorafenib initiation for HCC. Careful follow-up is required after commencing sorafenib therapy for the early diagnosis and management of TLS.

Citations

Citations to this article as recorded by  
  • A case of hepatocellular carcinoma caused severe tumor lysis by ramucirumab
    Yuhi Sakamoto, Keizo Kato, Hiroshi Abe, Takeshi Yonezawa, Sadahiro Ito, Makiko Ika, Kiichiro Yoza, Mamika Ohara, Shogo Sakasai, Shohei Shimizu, Shinji Endo
    Kanzo.2021; 62(3): 129.     CrossRef
  • Sorafenib-induced tumor lysis syndrome in a patient with metastatic hepatocellular carcinoma
    Sardar Zakariya Imam, Mohammad Faizan Zahid, Muhammad Asad Maqbool
    Hematology/Oncology and Stem Cell Therapy.2020; 13(3): 168.     CrossRef
A Case of Mixed Papillary Thyroid Tumor and Squamous-Cell Carcinoma.
Ho Su Kim, Jong Ryeal Hahm, Tae Sik Jung, Jung Hwa Jung, Soo Kyoung Kim, Sang Min Lee, Soon Il Chung
Yeungnam Univ J Med. 2011;28(2):206-210.   Published online December 31, 2011
DOI: https://doi.org/10.12701/yujm.2011.28.2.206
  • 1,700 View
  • 1 Download
  • 1 Crossref
AbstractAbstract PDF
The occurrence of a mixed tumor containing papillary thyroid carcinoma (PTC) and primary squamous-cell carcinoma (SCC) is rare because there is no squamous epithelium in the thyroid gland. Reported herein is a 30-year-old female with mixed PTC and primary SCC of the thyroid presented as thyroid incidentaloma. Fine-needle aspiration biopsy of the thyroid nodule revealed the presence of malignant thyroid cells. The histopathological examination following total thyroidectomy yielded two mixed, morphologically distinct histotypes that included PTC and SCC. After total thyroidectomy, the patient underwent radioactive iodine therapy. No recurrence or metastasis occurred during the 20-month follow-up period after the operation.

Citations

Citations to this article as recorded by  
  • Meta-Analysis of Squamous Cell Carcinoma of Thyroid
    Hyun Seok Shim, Oh Jin Kwon, Joon Seok Ko, Jung Je Park, Jin Pyeong Kim, Chan Ryeul Jeong, Seung Hoon Woo
    Korean Journal of Otorhinolaryngology-Head and Neck Surgery.2013; 56(7): 425.     CrossRef

JYMS : Journal of Yeungnam Medical Science